High hCG level is a risk factor for predicting the occurrence of brain and/or liver metastases from gestational choriocarcinoma

International Journal of Gynecology and Obstetrics

Volumn 65, Issue 1, 1999, Pages 67-69

  Yuan, C C ^a   Wang, P H ^a   Ng, H T ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Brain and or liver metastases; Choriocarcinoma; hCG

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE; VINCRISTINE SULFATE;

ADULT; ARTICLE; BRAIN METASTASIS; CANCER SURVIVAL; CHORIOCARCINOMA; FEMALE; HORMONE BLOOD LEVEL; HUMAN; LIVER METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TROPHOBLASTIC DISEASE;

EID: 0032941347     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7292(98)00209-4     Document Type: Article

References (4)

1. Small W, Jr, Lurain JR, Shetty RM, Huang CF, Applegate GL, Brannd WN. Gestational trophoblastic disease metastatic to brain. Radiology 1996;200:277-280.
2. Wong LC, Choo YC, Ma HK. Hepatic metastases in gestational trophoblastic disease. Obstet Gynecol 1986;67:107-111.
3. Wang PH, Yuan CC, Tseng JY, Chao HT. High-risk gestational trophoblastic disease: analysis of clinical prognosis. Eur J Gynecol Oncol 1998;19:302-305.
4. Soper JT, Evans AC, Conaway MR, Clarke-Pearson DL, Berchuck A, Hammond CB. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol 1994;84:969-973.